Full US Prescribing Information
Indication Statement for applicable product
RETIN-A MICRO® (tretinoin gel) microsphere, 0.04% and 0.1% are indicated for topical application in the treatment of acne vulgaris.
Important Safety Information:
RETIN-A MICRO® (tretinoin gel) microsphere, 0.04% and 0.1% should not be used if you have a known sensitivity or allergy to any of its components. During the first weeks of treatment you may experience dryness, redness, or peeling which should decrease over time. If you experience irritation, your doctor may direct you to use the medication differently. Unprotected exposure to sun or tanning lights, extreme wind or cold, or use of irritating skin-care products may aggravate the skin. Use of a sunscreen with a SPF 15 or higher is recommended. RETIN-A MICRO 0.04% and 0.1% start working in as little as 2 weeks, with full results after 7 weeks.
You will need Adobe® Acrobat Reader® in order to view the full US prescribing information.
If you already have Adobe® Acrobat Reader®, view:
If you do not already have Adobe Acrobat Reader, you can download it for free from the Adobe website.
Adobe and Acrobat Reader are registered trademarks of Adobe Systems Incorporated.
